Navigation Links
AbbVie to Host Third-Quarter Earnings Conference Call
Date:10/6/2015

NORTH CHICAGO, Ill., Oct. 6, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2015 financial results on Friday, Oct. 30, 2015, before the market opens.

AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern). It will be accessible through AbbVie's Investor Relations website at www.abbvieinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

 


'/>"/>
SOURCE AbbVie
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
2. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
3. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
4. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
5. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
6. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
7. AbbVie Declares Quarterly Dividend
8. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
9. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
10. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
11. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2018)... ... 05, 2018 , ... BioPlus Specialty Pharmacy (BioPlus), ... from a company-matched employee giving program to provide support for those affected in ... for specialty pharmacy care for medical offices, patients, pharmaceutical companies, payers, and employees ...
(Date:10/5/2018)... ... ... September 20th article in the Richmond Times-Dispatch reports on the death of a ... be the result of a head trauma. As the article points out, the tragedy comes ... helmetless scooter driving for adults. Los Angeles based personal injury law firm ...
(Date:10/5/2018)... PEKIN, Ill. (PRWEB) , ... October 05, 2018 ... ... (iaedp.com) proudly announces the second call for entries for its annual “Imagine Me ... promote healthy awareness and acceptance of body images. The competition incorporates mannequins ...
Breaking Medicine Technology:
(Date:10/13/2018)... ... ... At HEI Health, we believe tomorrow’s healthcare can be made affordable today. HEI ... Fall Summit by Marcus Evans. HEI will be hosting an exclusive round table session ... healthcare providers. , Marcus Evans National Healthcare CXO Summit is the premium forum ...
(Date:10/13/2018)... ... October 13, 2018 , ... This World Food Day – Tuesday, October 16 ... to end hunger by 2030 by breaking a GUINNESS WORLD RECORDS title with volunteers ... U.S. based locations and five international locations together to break the GUINNESS WORLD RECORDS ...
(Date:10/11/2018)... ... 11, 2018 , ... The Danisco Foundation today has awarded ... fields recognized by DuPont Nutrition & Health for scientific excellence and a remarkable ... food, nutrition and health. , This year’s medalists are: , ? DuPont Nutrition ...
(Date:10/11/2018)... ... October 11, 2018 , ... Bizmatics Inc. is a ... and specialties. PrognoCIS , their Health IT Software – provides physicians with ... Houston Healthconnect (GHH), the region’s health information exchange (HIE), serves 24 counties in ...
(Date:10/6/2018)... (PRWEB) , ... October 06, 2018 , ... ... standards for healthcare treatment professionals who treat the full spectrum of eating disorders ... the organization’s Presidents Council. , “As with each of our Presidents Council members, ...
Breaking Medicine News(10 mins):